{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:00:54Z","timestamp":1792098054461,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10384-012-0202-z","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T20:13:22Z","timestamp":1351541602000},"page":"104-107","source":"Crossref","is-referenced-by-count":13,"title":["Treatment of recurrent anterior uveitis with infliximab in patient with ankylosing spondylitis"],"prefix":"10.1007","volume":"57","author":[{"given":"Junko","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Numaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"202_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"key":"202_CR2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","volume":"50","author":"JH Chang","year":"2005","unstructured":"Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50:364\u201388.","journal-title":"Surv Ophthalmol"},{"key":"202_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0039-6257(91)90005-Z","volume":"36","author":"D Wakefield","year":"1991","unstructured":"Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 1991;36:223\u201332.","journal-title":"Surv Ophthalmol"},{"key":"202_CR4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bjo.81.12.1107","volume":"81","author":"AD Dick","year":"1997","unstructured":"Dick AD, Azim M, Forrester JV. Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol. 1997;81:1107\u201312.","journal-title":"Br J Ophthalmol"},{"key":"202_CR5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","volume":"14","author":"JM Benitez-Del-Castillo","year":"2000","unstructured":"Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Ba\u00f1ares A. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye. 2000;14:340\u20133.","journal-title":"Eye"},{"key":"202_CR6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Rodevand E, Holck P, Vanhoof J, Kron M, Kary S, et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis. 2009;68:696\u2013701.","journal-title":"Ann Rheum Dis"},{"key":"202_CR7","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/S0161-6420(02)01292-7","volume":"109","author":"Y El-Shabrawi","year":"2002","unstructured":"El-Shabrawi Y, Hermann J. Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology. 2002;109:2342\u20136.","journal-title":"Ophthalmology"},{"key":"202_CR8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","volume":"110","author":"A Joseph","year":"2003","unstructured":"Joseph A, Raj D, Dua HS, Powell PT, Lanyon PC, Powell RJ. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology. 2003;110:1449\u201353.","journal-title":"Ophthalmology"},{"key":"202_CR9","first-page":"1362","volume":"31","author":"S Ohno","year":"2004","unstructured":"Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et\u2019s disease with refractory uveoretinitis. J Rheumatol. 2004;31:1362\u20138.","journal-title":"J Rheumatol"},{"key":"202_CR10","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","volume":"52","author":"J Braun","year":"2005","unstructured":"Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005;52:2447\u201351.","journal-title":"Arthritis Rheum"},{"key":"202_CR11","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","volume":"113","author":"A Galor","year":"2006","unstructured":"Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology. 2006;113:2317\u201323.","journal-title":"Ophthalmology"},{"key":"202_CR12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","volume":"43","author":"J Brandt","year":"2000","unstructured":"Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, et al. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha. monoclonal antibody infliximab. Arthritis Rheum. 2000;43:1346\u201352.","journal-title":"Arthritis Rheum"},{"key":"202_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","volume":"126","author":"JF Colombel","year":"2004","unstructured":"Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, et al. The safety profile of infliximab in patients with Crohn\u2019s disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004;126:19\u201331.","journal-title":"Gastroenterology"},{"key":"202_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/09273948.2010.496914","volume":"18","author":"M Papadia","year":"2010","unstructured":"Papadia M, Herbort CP. Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis. Ocul Immunol Inflamm. 2010;18:482\u20134.","journal-title":"Ocul Immunol Inflamm"},{"key":"202_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.17.2.209","volume":"17","author":"M Wilkinson","year":"1958","unstructured":"Wilkinson M, Bywasters EG. Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases. Ann Rheum Dis. 1958;17:209\u201328.","journal-title":"Ann Rheum Dis"},{"key":"202_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-9394(14)72165-8","volume":"120","author":"A Linssen","year":"1995","unstructured":"Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol. 1995;120:351\u201361.","journal-title":"Am J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-012-0202-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0202-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:20:36Z","timestamp":1559146836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-012-0202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s10384-012-0202-z","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]}}}